Variable* | Patients | % |
---|---|---|
Gender | Â | Â |
   Males | 573 | 57.2 |
   Females | 429 | 42.8 |
Family History | Â | Â |
   Yes | 167 | 16.7 |
   No | 826 | 82.4 |
   Unknown | 9 | 0.9 |
Multi-primary Melanoma | Â | Â |
   Yes | 152 | 15.2 |
   No | 849 | 84.7 |
   Unknown | 1 | 0.1 |
Stage at Diagnosis | Â | Â |
   0 | 58 | 5.8 |
   I | 504 | 50.3 |
   II | 235 | 23.4 |
   III | 169 | 16.9 |
   IV | 9 | 0.9 |
   Unstagable¥ | 27 | 2.7 |
Current Stage | Â | Â |
   0 | 56 | 5.6 |
   I | 435 | 43.4 |
   II | 159 | 15.9 |
   III | 217 | 21.7 |
   IV | 129 | 12.9 |
   Unstagable¥ | 6 | 0.5 |
Primary Clark Level | Â | Â |
   I | 58 | 5.8 |
   II | 108 | 10.8 |
   III | 150 | 14.9 |
   IV | 489 | 48.8 |
   V | 69 | 6.9 |
   Unknown | 128 | 12.8 |
Thickness (mm) | Â | Â |
   In situ | 58 | 5.8 |
   < 1.01 | 321 | 32.0 |
   1.01 – 2.00 | 272 | 27.1 |
   2.01 – 4.00 | 161 | 16.1 |
   > 4.00 | 121 | 12.1 |
   Unknown | 69 | 6.9 |
Tumor Infiltrating Lymphocytes (TILs) | Â | Â |
   Absent | 206 | 20.6 |
   Non-brisk | 397 | 39.6 |
   Brisk | 31 | 3.1 |
   unknown | 368 | 36.7 |
Distant Metastasis | Â | Â |
   Yes | 130 | 13.0 |
   No | 870 | 86.8 |
   N/Aϕ | 2 | 0.2 |
Intransit Metastasis | Â | Â |
   No | 942 | 94.0 |
   Yes | 27 | 2.7 |
   N/Aϕ | 33 | 3.3 |
Number of Moles | Â | Â |
   None | 260 | 25.9 |
   Few | 498 | 49.7 |
   Moderate | 169 | 16.9 |
   Many | 40 | 4.0 |
   N/Aϕ | 35 | 3.5 |
Phenotypic Index | Â | Â |
   1 (low risk) | 38 | 3.8 |
   2 | 210 | 21.0 |
   3 | 317 | 31.6 |
   4 | 328 | 32.7 |
   5 (high risk) | 105 | 10.5 |
   N/Aϕ | 4 | 0.4 |
Site of the Primary Melanoma | Â | Â |
   Extremities | 535 | 53.4 |
   Trunk | 342 | 34.1 |
   Head and Neck | 71 | 7.1 |
   Non-cutaneousω | 12 | 1.2 |
   Unknown | 42 | 4.2 |